Association Between SGLT2 Inhibitor Treatment and Diabetic Ketoacidosis and Mortality in People With Type 2 Diabetes Admitted to Hospital With COVID-19.
Diabetes Care
; 2022 Sep 08.
Article
en En
| MEDLINE
| ID: mdl-36074663
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Diabetes Care
Año:
2022
Tipo del documento:
Article
País de afiliación:
Reino Unido